Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial
暂无分享,去创建一个
M. Pfeffer | P. Jose | E. Braunwald | F. Sacks | M. Tonelli | G. Curhan
[1] D. Marcelli,et al. Factors affecting progression of renal insufficiency. , 1997, Mineral and electrolyte metabolism.
[2] Charles E McCulloch,et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.
[3] M. Mcclellan,et al. Association of Renal Insufficiency with Treatment and Outcomes after Myocardial Infarction in Elderly Patients , 2002, Annals of Internal Medicine.
[4] Hans L Hillege,et al. Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population , 2002, Circulation.
[5] J. Coresh,et al. Adjusting survival curves for confounders: a review and a new method. , 1996, American journal of epidemiology.
[6] D. Levy,et al. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. , 1999, Kidney international.
[7] Robert M Califf,et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. , 2004, The New England journal of medicine.
[8] HOMAS,et al. The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels , 2000 .
[9] A. Garg,et al. Association between renal insufficiency and malnutrition in older adults: results from the NHANES III. , 2001, Kidney international.
[10] B. Kasiske,et al. Proteinuria is a risk factor for mortality over 10 years of follow-up. MRFIT Research Group. Multiple Risk Factor Intervention Trial. , 1997, Kidney international. Supplement.
[11] A. Garg,et al. Albuminuria and renal insufficiency prevalence guides population screening: Results from the NHANES III , 2002 .
[12] D. Levy,et al. Proteinuria as a risk factor for cardiovascular disease and mortality in older people: a prospective study. , 2000, The American journal of medicine.
[13] P. Jungers,et al. Effects of blood pressure and antihypertensive treatment on progression of advanced chronic renal failure. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[14] R. Foley,et al. Clinical epidemiology of cardiovascular disease in chronic renal disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[15] Bertram L Kasiske,et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Hypertension.
[16] J. Manson,et al. Kidney dysfunction, inflammation, and coronary events: a prospective study. , 2004, Journal of the American Society of Nephrology : JASN.
[17] M. Pfeffer,et al. Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: a case for albuminuria. , 2004, Kidney international. Supplement.
[18] A. Levin,et al. Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[19] B. Kasiske. The Kidney in Cardiovascular Disease , 2001, Annals of Internal Medicine.
[20] C. Wanner,et al. Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage? , 2002, Kidney international.
[21] G. Beck,et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. , 1997, Kidney international.
[22] R. Gans,et al. C-reactive protein and microalbuminuria differ in their associations with various domains of vascular disease. , 2004, Atherosclerosis.
[23] M. Blaufox,et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. , 1989, Hypertension.
[24] A. Garg,et al. Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. , 2003, Kidney international.
[25] E. Pohanka,et al. PROGRESSION OF CHRONIC RENAL FAILURE , 1988, The Lancet.
[26] S. Borzak,et al. Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease. , 2002, American heart journal.
[27] S. Cañadillas,et al. Importance of arachidonic acid as a mediator of parathyroid gland response. , 2003, Kidney international. Supplement.
[28] K. Borch-Johnsen,et al. Elevated Urinary Albumin Excretion Is Associated With Impaired Arterial Dilatory Capacity in Clinically Healthy Subjects , 2001, Circulation.
[29] K. Borch-Johnsen,et al. Preventive cardiology: abstractVery low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes☆ , 2004 .
[30] S. Yusuf,et al. Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial , 2001, Annals of Internal Medicine.
[31] A. Zanchetti,et al. Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. , 2001, Journal of the American Society of Nephrology : JASN.
[32] M. Nieminen,et al. Albuminuria and Cardiovascular Risk in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study , 2003, Annals of Internal Medicine.
[33] B. Psaty,et al. Cardiovascular disease risk status in elderly persons with renal insufficiency. , 2002, Kidney international.
[34] M. Pfeffer,et al. Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: the Cholesterol and Recurrent Events trial (CARE) , 1991, The American journal of cardiology.
[35] P. Armstrong,et al. Renal Insufficiency and Heart Failure: Prognostic and Therapeutic Implications From a Prospective Cohort Study , 2004, Circulation.
[36] C. Mogensen,et al. Microalbuminuria as predictor of increased mortality in elderly people. , 1990, BMJ.